Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Moogeh Baharnoori"'
Autor:
Virender Bhan, Fraser Clift, Moogeh Baharnoori, Kimberly Thomas, Barkha P Patel, Francois Blanchette, Nicholas Adlard, Umakanth Vudumula, Kapil Gudala, Nikkita Dutta, Daniel Grima, Soukaina Mouallif, Fatine Farhane
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 9 (2023)
Aim: The costs and consequences of initial and delayed ofatumumab treatment were evaluated in relapsing-remitting multiple sclerosis with active disease in Canada. Materials & methods: A Markov cohort model was used (10-year horizon, annual cycle l
Externí odkaz:
https://doaj.org/article/28912569120748138041870a3a8c4948
Autor:
Neda Sattarnezhad, Brian C. Healy, Moogeh Baharnoori, Camilo Diaz-Cruz, James Stankiewicz, Howard L. Weiner, Tanuja Chitnis
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background To compare the effectiveness of dimethyl fumarate (DMF) with subcutaneous interferon beta-1a (IFNβ-1a) in controlling disease activity in patients with relapsing–remitting Multiple Sclerosis (MS). Methods Clinical and imaging d
Externí odkaz:
https://doaj.org/article/d7f3ee1685bf49ccb707649015e23369
Autor:
Moogeh Baharnoori, Daniel M. Mandell, Danielle M. Andrade, Eva W.C. Chow, Anne S. Bassett, Tim-Rasmus Kiehl
Publikováno v:
Human Pathology: Case Reports, Vol 9, Iss , Pp 55-57 (2017)
22q11.2 deletion syndrome (22q11DS) is the most common pathogenic copy number variant in humans. Neuropsychiatric phenotypes, including schizophrenia, are prominent. Imaging studies of individuals with this syndrome show a variety of abnormalities th
Externí odkaz:
https://doaj.org/article/0f10a1adf9a64291b0f2b63c89f87f75
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54439 (2013)
Epidemiological evidence supports that maternal infection during gestation are notable risk factors for developmental mental illnesses including schizophrenia and autism. In prenatal lipopolysaccharide (LPS) model of immune activation in rats, the of
Externí odkaz:
https://doaj.org/article/c2e789579ed347498fa8308f9cce34e2
Autor:
Moogeh, Baharnoori, Virender, Bhan, Fraser, Clift, Kimberly, Thomas, Soukaïna, Mouallif, Nicholas, Adlard, Philip, Cooney, François, Blanchette, Barkha P, Patel, Daniel, Grima
Publikováno v:
PharmacoEconomics - Open. 6:859-870
Ofatumumab is a high-efficacy disease-modifying therapy (DMT) approved for first-line treatment of relapsing-remitting multiple sclerosis (RRMS) in Canada.The aim of this study was to evaluate the cost effectiveness of ofatumumab from a Canadian heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f44d876d250f6588064ef41c5c472f8
https://doi.org/10.1007/s41669-022-00363-1
https://doi.org/10.1007/s41669-022-00363-1
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47:727-730
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82edc0b02ef18b83472410b9c559f3f
https://doi.org/10.1017/cjn.2020.59
https://doi.org/10.1017/cjn.2020.59
Publikováno v:
American Journal of Therapeutics. 26:e481-e484
Most epidemiological studies indicate that incidence of cancer in multiple sclerosis patients is lower than general population. However these studies were performed prior to the emergence of disease-modifying therapies (DMTs). The incidence of cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22b1fade2cf262fde628cc77e31f1c58
https://doi.org/10.1097/mjt.0000000000000694
https://doi.org/10.1097/mjt.0000000000000694
Autor:
Nader Ghasemlou, Julia P. Segal, Courtney A. Bannerman, Ian Gilron, Cortney M. Haird, Jaqueline Raymondi Silva, Moogeh Baharnoori
Publikováno v:
Brain, behavior, and immunity. 89
Chronic pain severely affects quality of life in more than half of people living with multiple sclerosis (MS). A commonly-used model of MS, experimental autoimmune encephalomyelitis (EAE), typically presents with hindlimb paralysis, neuroinflammation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b426bd22d64bec91ba6a0b882ad7725
https://pubmed.ncbi.nlm.nih.gov/32688029
https://pubmed.ncbi.nlm.nih.gov/32688029
Autor:
Simmatis, Leif ER, Jin, Albert Y, Taylor, Sean W, Bisson, Etienne J, Scott, Stephen H, Moogeh Baharnoori
Supplemental material, sj-pdf-1-mso-10.1177_2055217320964940 for The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics by Leif ER Simmatis, Albert Y Jin, Sean W Taylor, Etienne J Bisson, Stephen H Sco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba03ed3bdb2af13d19f6465fcdfd9e5b
Autor:
Moogeh Baharnoori, James Stankiewicz, Camilo Diaz-Cruz, Alicia S. Chua, Tanuja Chitnis, Brian C. Healy, Howard L. Weiner, Cindy T Gonzalez
Publikováno v:
Multiple Sclerosis and Related Disorders. 20:51-57
There is limited data regarding the predictors of hematological abnormalities in multiple sclerosis (MS) patients treated with dimethyl fumarate (DMF) or fingolimod (FNG), and the impact of treatment switch on lymphocyte and leukocyte count METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa734857afbc4daf3e2b48ff89ca001
https://doi.org/10.1016/j.msard.2017.12.003
https://doi.org/10.1016/j.msard.2017.12.003